Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TEMODAL for Malignant glioma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where TEMODAL was used for Malignant glioma.

Most Reported Side Effects for TEMODAL

Side Effect Reports % Deaths Hosp.
Bone marrow failure 6 7.2% 4 3
Brain oedema 6 7.2% 0 2
Disease progression 6 7.2% 5 3
Thrombocytopenia 6 7.2% 2 5
Pancytopenia 5 6.0% 2 3
Platelet count decreased 5 6.0% 2 3
Pneumonia 5 6.0% 3 3
Pyrexia 5 6.0% 1 3

Other Indications for TEMODAL

Glioblastoma (20) Glioblastoma multiforme (18) Anaplastic astrocytoma (7)

Other Drugs Used for Malignant glioma

BEVACIZUMAB (230) TEMOZOLOMIDE (206) CARMUSTINE (91) IRINOTECAN (37) PEMBROLIZUMAB (29) GLIADEL (28) CARBOPLATIN (25) NIVOLUMAB (17) ERLOTINIB (16) TEMSIROLIMUS (11)

Related Pages

TEMODAL Full Profile All Malignant glioma Drugs TEMODAL Demographics TEMODAL Timeline